Tredje AP fonden Lowers Stock Position in Colgate-Palmolive (NYSE:CL)

Tredje AP fonden cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 35.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 197,500 shares of the company’s stock after selling 110,500 shares during the period. Tredje AP fonden’s holdings in Colgate-Palmolive were worth $17,955,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of CL. Kohmann Bosshard Financial Services LLC purchased a new position in Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC purchased a new position in Colgate-Palmolive in the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter valued at $32,000. Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive in the 4th quarter valued at $32,000. Finally, Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive in the 4th quarter valued at $36,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CL. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Raymond James reissued an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $101.61.

Colgate-Palmolive Trading Down 3.6 %

NYSE:CL opened at $90.71 on Thursday. The company has a market capitalization of $73.61 billion, a PE ratio of 25.77, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The stock has a fifty day simple moving average of $89.03 and a 200-day simple moving average of $94.96. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 earnings per share. On average, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.